Doxycycline monotherapy for pyoderma vegetans: a case report

J Dermatolog Treat. 2024 Dec;35(1):2329248. doi: 10.1080/09546634.2024.2329248. Epub 2024 Mar 13.

Abstract

Background: Pyoderma vegetans (PV) is a rare neutrophilic dermatosis of unknown etiology. Currently, there are no treatment guidelines for PV. Systemic steroids are often used as first-line therapy, but recurrence upon discontinuation or tapering is common.Materials and methods: We tested the efficacy of doxycycline at a dose of 200 mg/d to treat resistant PV.Results: After 4 weeks of treatment we noticed a significant improvement in the clinical appearance of PV.Conclusions: Our case demonstrates the potential utility of doxycycline as a systemic steroid-sparing agent in the treatment of PV.

Keywords: Neutrophilic dermatosis; doxycycline; pyoderma vegetans; systemic steroid-sparing agent.

Publication types

  • Case Reports

MeSH terms

  • Doxycycline / therapeutic use
  • Humans
  • Organic Chemicals
  • Pemphigus*
  • Pyoderma Gangrenosum*
  • Pyoderma* / drug therapy
  • Pyoderma* / etiology
  • Skin Diseases, Bacterial*

Substances

  • Doxycycline
  • vegetan
  • Organic Chemicals